This table refers to DOAC use in individuals who have undergone bariatric procedures but does not apply to the immediate post-surgical period. Close consultation between all clinical teams is prudent in determining the optimal approach. Refer to product information and additional discussion in UpToDate.
From: Martin KA, Beyer-Westendorf J, Davidson BL, et al. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost 2021; 19:1874.
https://onlinelibrary.wiley.com/doi/10.1111/jth.15358. Copyright © 2021 John Wiley & Sons Ltd. Adapted with permission of John Wiley & Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email:
permissions@wiley.com or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (
https://onlinelibrary.wiley.com/).